** Shares of life sciences firms Thermo Fisher Scientific TMO.N and Danaher DHR.N rise over 2% in premarket trade
** Franco-German peer Sartorius' SATG.DE Q4 orders in its key bioprocess solutions division (BPS) rose 23.1% to 856.7 million euros
** SATG also reports annual underlying earnings before interest, tax, depreciation and amortisation (EBITDA) of 945 mln euros ($984.78 mln), topping a Vara consensus estimate of 932.7 mln
** With the significant orders beat and another quarter of sequential BPS order improvement, we view the SATG results as a positive data point for AVTR, DHR and TMO, and expect the group to trade well - brokerage Citi Research
** Shares of Avantor AVTR.N were up marginally premarket
** In 2024, AVTR fell 7.7%, DHR fell 0.8% and TMO fell 2%
($1 = 0.9596 euros)
(Reporting by Puyaan Singh)
((Puyaan.Singh@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。